Amy E. Wright
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Amy E. Wright has a total of 17 co-authors. Here are the top co-authors by number of shared publications:
- Peter J. McCarthy
Harbor Branch Oceanographic Institute, Florida Atlantic University, Fort Pierce, FL 34946, USA
2 shared publications Shirley A. Pomponi
Center for Ocean Exploration, Biomedical Marine Research Program, Harbor Branch Oceanographic Institution, Inc., 5600 US 1 North, Ft. Pierce, Florida 34946
2 shared publicationsTara P. Pitts
Center for Ocean Exploration, Biomedical Marine Research Program, Harbor Branch Oceanographic Institution, Inc., 5600 US 1 North, Ft. Pierce, Florida 34946
2 shared publicationsDedra Harmody
Center for Ocean Exploration, Biomedical Marine Research Program, Harbor Branch Oceanographic Institution, Inc., 5600 US 1 North, Ft. Pierce, Florida 34946
1 shared publication- Esther Amalia Guzmán
Marine Biomedical and Biotechnology Research, Harbor Branch Oceanographic Institute, Florida Atlantic University, 5600 US 1 North, Fort Pierce, FL 34946, USA
1 shared publication - Ian Paterson
University Chemical Laboratory, University of Cambridge, UK
1 shared publication
Latest Publications
- 20 February 2007
- Published by American Chemical Society (ACS) in Journal of Natural Products
- Vol. 70 (3) , 412-416
Neopeltolide, a Macrolide from a Lithistid Sponge of the Family Neopeltidae
A new marine-derived macrolide designated as neopeltolide (1) has been isolated from a deep-water sponge of the family Neopeltidae. Its structure was elucidated on the basis of spectroscopic data interpretation. Neopeltolide (1) is a potent inhibitor of the in vitro proliferation of the A-549 human lung adenocarcinoma, the NCI-ADR-RES human ovarian sarcoma, and the P388 murine leukemia cell lines, with IC50's of 1.2, 5.1, and 0.56 nM, respectively. Neopeltolide (1) also inhibited the growth of the fungal pathogen Candida albicans with a minimum inhibitory concentration of 0.62 μg/mL.
- 20 February 2007
- Published by American Chemical Society (ACS) in Journal of Natural Products
- Vol. 70 (3) , 412-416
Neopeltolide, a Macrolide from a Lithistid Sponge of the Family Neopeltidae
A new marine-derived macrolide designated as neopeltolide (1) has been isolated from a deep-water sponge of the family Neopeltidae. Its structure was elucidated on the basis of spectroscopic data interpretation. Neopeltolide (1) is a potent inhibitor of the in vitro proliferation of the A-549 human lung adenocarcinoma, the NCI-ADR-RES human ovarian sarcoma, and the P388 murine leukemia cell lines, with IC50's of 1.2, 5.1, and 0.56 nM, respectively. Neopeltolide (1) also inhibited the growth of the fungal pathogen Candida albicans with a minimum inhibitory concentration of 0.62 μg/mL.
- 21 July 2004
- Published by American Chemical Society (ACS) in Journal of Natural Products
- Vol. 67 (8) , 1351-1355
Lasonolides C−G, Five New Lasonolide Compounds from the Sponge Forcepia sp.
Five new marine-derived macrolide compounds, lasonolides C (3), D (4), E (5), F (6), and G (7), have been isolated from the sponge Forcepia sp. along with the parent compound in the series, lasonolide A (1). Their structures were elucidated on the basis of spectral data. Compounds 3−5 inhibit the in vitro proliferation of A-549 human lung adenocarcinoma cells with IC50's of 0.13, 4.5, and 0.31 μM, respectively. Compounds 3−6 inhibit the in vitro proliferation of PANC-1 human pancreatic carcinoma cells with IC50's of 0.38, 4.89, 0.57, and 15.6 μM, respectively. Compound 3 inhibits the in vitro proliferation of the NCI-ADR-RES cell line with an IC50 of 1.12 μM.
- 21 July 2004
- Published by American Chemical Society (ACS) in Journal of Natural Products
- Vol. 67 (8) , 1351-1355
Lasonolides C−G, Five New Lasonolide Compounds from the Sponge Forcepia sp.
Five new marine-derived macrolide compounds, lasonolides C (3), D (4), E (5), F (6), and G (7), have been isolated from the sponge Forcepia sp. along with the parent compound in the series, lasonolide A (1). Their structures were elucidated on the basis of spectral data. Compounds 3−5 inhibit the in vitro proliferation of A-549 human lung adenocarcinoma cells with IC50's of 0.13, 4.5, and 0.31 μM, respectively. Compounds 3−6 inhibit the in vitro proliferation of PANC-1 human pancreatic carcinoma cells with IC50's of 0.38, 4.89, 0.57, and 15.6 μM, respectively. Compound 3 inhibits the in vitro proliferation of the NCI-ADR-RES cell line with an IC50 of 1.12 μM.
- 9 February 2004
- Published by Royal Society of Chemistry (RSC) in Chemical Communications
- No. 6,p. 632-633
Stereochemical determination of dictyostatin, a novel microtubule-stabilising macrolide from the marine sponge Corallistidae sp.Electronic supplementary information (ESI) available: copies of 1D and 2D NMR spectra, tables of spectral data and calculated torsion angles. See http://www.rsc.org/suppdata/cc/b3/b316390c/
The relative stereochemistry of the 22-membered marine macrolide dictyostatin, a Taxol-like antimitotic agent, was determined based on a combination of extensive high field NMR studies, including J-based configuration analysis, and molecular modelling.
- 9 February 2004
- Published by Royal Society of Chemistry (RSC) in Chemical Communications
- No. 6,p. 632-633
Stereochemical determination of dictyostatin, a novel microtubule-stabilising macrolide from the marine sponge Corallistidae sp.Electronic supplementary information (ESI) available: copies of 1D and 2D NMR spectra, tables of spectral data and calculated torsion angles. See http://www.rsc.org/suppdata/cc/b3/b316390c/
The relative stereochemistry of the 22-membered marine macrolide dictyostatin, a Taxol-like antimitotic agent, was determined based on a combination of extensive high field NMR studies, including J-based configuration analysis, and molecular modelling.
- 1 January 1995
- Published by Taylor & Francis in International Journal of Pharmacognosy
- Vol. 33 (3) , 253-255
Antimicrobial Constituent of the Brown Alga Sporochnus pedunculatus
Bioassay-guided fractionation of the ethanol extract of the brown alga Sporochnus pedunculatus led to the isolation of 2-(3′-methylbut-2′-enyl)-4- (1″, 1″-dimethylprop-2″ -enyl) phenol (1) as the only antimicrobial compound. This compound is a growth inhibitor of Candida albicans, Cryptococcus neoformans, and Bacillus subtilis. In this paper we report the isolation, identification, and biological activity of 1.
- 1 January 1995
- Published by Taylor & Francis in International Journal of Pharmacognosy
- Vol. 33 (3) , 253-255
Antimicrobial Constituent of the Brown Alga Sporochnus pedunculatus
Bioassay-guided fractionation of the ethanol extract of the brown alga Sporochnus pedunculatus led to the isolation of 2-(3′-methylbut-2′-enyl)-4- (1″, 1″-dimethylprop-2″ -enyl) phenol (1) as the only antimicrobial compound. This compound is a growth inhibitor of Candida albicans, Cryptococcus neoformans, and Bacillus subtilis. In this paper we report the isolation, identification, and biological activity of 1.